Cloudbreak Pharma Inc. (HKG:2592)
Hong Kong · Delayed Price · Currency is HKD 1.200
-0.090 (-6.98%)
At close: Jun 1, 2026
Cloudbreak Pharma Revenue
In the year 2025, Cloudbreak Pharma had annual revenue of $253.00K USD, down -97.52%. Cloudbreak Pharma had revenue of $225.00K in the half year ending December 31, 2025.
Revenue
$253.00K
Revenue Growth
-97.52%
P/S Ratio
514.66
Revenue / Employee
$4.15K
Employees
61
Market Cap
1.01B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 253.00K | -9.96M | -97.52% |
| Dec 31, 2024 | 10.21M | 9.33M | 1,060.68% |
| Dec 31, 2023 | 880.00K | 409.00K | 86.84% |
| Dec 31, 2022 | 471.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition